TCL Archive FDA unlikely to pull Iressa from market. Iressa a case study in how not to develop a drug, ODAC member says. April 1, 2005
TCL Archive DeVita Alert Advises That Negative Node Breast Cancer Patients Do Better With Adjuvant Therapy May 27, 1988
TCL Archive Q & A With Shannon Brownlee: Task Force Independence at Stake In Debate over PSA Screening October 6, 2011
